路易体病的病程与病理相关性
该观察性研究纳入807例过渡型或弥漫型路易体病(LBD)患者,分析病理变量与病程的关系。结果显示弥漫型LBD、男性及发病年龄较晚与认知症状出现至死亡的时间更短相关,而Braak神经原纤维缠结分期和神经炎性斑块与病程无显著关联。
要点
- 弥漫型LBD较过渡型LBD病程更短。
- 男性及发病年龄较晚者病程更短。
- Braak NFT分期和神经炎性斑块与病程无关。
核心结论
- 弥漫型LBD与过渡型LBD相比病程更短,且该效应独立于Braak NFT分期或神经炎性斑块病变程度。
研究设计与样本
- 观察性研究,使用美国国家阿尔茨海默病协调中心数据库,纳入807例过渡型或弥漫型LBD参与者,研究时间为2005年9月1日至2015年6月1日。
主要发现
- Braak NFT分期和神经炎性斑块的存在与病程差异无显著关联。
临床怎么用
- 弥漫型LBD、男性及发病年龄较晚可提示DLB患者病程更短,或有助于预后沟通。
- 识别LBD分期的生前生物标志物可能为DLB患者提供重要预后信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Although patients with dementia with Lewy bodies (DLB) have shorter disease duration than patients with Alzheimer disease dementia, little is known about which factors influence disease duration among patients with DLB. OBJECTIVE: To identify pathologic correlates of disease duration in participants with Lewy body disease (LBD). DESIGN, SETTING, AND PARTICIPANTS: This observational study, performed from September 1, 2005, to June 1, 2015, using the National Alzheimer's Coordinating Center database included 807 participants with transitional or diffuse LBD. MAIN OUTCOMES AND MEASURES: The study used Braak neurofibrillary tangle (NFT) stage, frequency of neuritic plaques, and LBD stage to determine whether pathologic variables are associated with disease duration. RESULTS: This study included 807 participants with transitional or diffuse LBD (mean [SD] age, 70.0 [9.9] at the onset of cognitive decline and 79.2 [9.8] years at death; 509 male [63.1%]). Shorter disease duration from cognitive symptom onset to death was observed in men (β, -0.73; 95% CI, -1.33 to -0.14; P = .02) and in those with a later age at onset (β, -0.11; 95% CI, -0.14 to -0.08; P < .001). Diffuse (neocortical) LBD was associated with shorter disease duration compared with transitional LBD (β, -1.52; 95% CI, -2.11 to -0.93; P < .001). Braak NFT stage and the presence of neuritic plaques were not significantly associated with differences in disease duration. CONCLUSIONS AND RELEVANCE: Diffuse LBD was associated with shorter disease duration compared with transitional LBD, and this effect is independent of Braak NFT stage or extent of neuritic plaque disease. Identifying antemortem biomarkers of LBD stage may provide important prognostic information to patients with DLB.
引用
- Graff-Radford J, Aakre J, Savica R, et al. Duration and Pathologic Correlates of Lewy Body Disease. JAMA Neurol. 2017. PMID: 28114455. doi:10.1001/jamaneurol.2016.4926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。